NeOnc Technologies Holdings, Inc. (NTHI)
3.19
-0.01
(-0.31%)
USD |
NASDAQ |
Nov 06, 10:45
NeOnc Technologies Holdings Total Liabilities (Quarterly) : 23.76M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 23.76M |
| March 31, 2026 | 16.56M |
| December 31, 2025 | 20.33M |
| September 30, 2025 | 15.90M |
| June 30, 2025 | 14.80M |
| March 31, 2025 | 18.07M |
| Date | Value |
|---|---|
| December 31, 2024 | 8.922M |
| September 30, 2024 | 8.011M |
| March 31, 2024 | |
| December 31, 2023 | 15.25M |
| September 30, 2023 | 11.24M |
| December 31, 2022 | 2.304M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 3.605M |
| CNBX Pharmaceuticals, Inc. | 2.672M |
| Arvinas, Inc. | 93.70M |
| Fulcrum Therapeutics, Inc. | 13.26M |
| Definium Therapeutics, Inc. | 194.22M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.232M |
| Shareholders Equity (Quarterly) | -18.53M |
| Debt to Equity Ratio | -0.0177 |
| Current Ratio | 0.1438 |
| Net Debt Paydown Yield | -0.06% |